The Guidelines Manual: Consultation on the 2008 update (1st April 2008)
NICE has carried out a review of ‘The guidelines manual’. This document describes the detailed process and methodology used to produce NICE clinical guidelines. It applies to both the NICE’s standard clinical guidelines and short clinical guidelines programmes. The draft update of ‘The guidelines manual’ is now open for consultation. Closing date for comments is 1st July 2008.
Click here for the Chapters
Click here for the Appendices
Click here for the Comments Proforma
Antenatal care: routine care for the healthy pregnant women Clinical Guideline CG62 (26th March 2008)
The advice in the NICE guideline covers: the routine care that all healthy women can expect to receive during their pregnancy. It does not specifically look at: women who are pregnant with more than one baby, women with certain medical conditions or women who develop a health problem during their pregnancy. This is an update of advice on 'Antenatal care: routine care for the healthy pregnant woman' that NICE produced in 2003.
Click here for the NICE Guideline
Click here for the Quick Reference Guide
Click here for the Full Guideline
Click here for the Search Strategies
Click here for the Evidence Tables
Click here for the Excluded Studies
Click here for Understanding NICE Guidance
Click here for the Costing Report
Click here for the Costing Template
Asthma (in adults) – corticosteroids Technology Appraisal TA138 (26th March 2008)
This guidance covers the use of inhaled corticosteroids to treat adults and children aged 12 years and over with chronic asthma in the NHS in England and Wales. It is written for people with chronic asthma but it may also be useful for their families or carers or anyone with an interest in the condition.
Click here for the Guidance
Click here for the Quick Reference Guide
Click here for the Understanding NICE Guidance
Click here for the Costing Statement
Click here for the Audit Support
Diabetes in Pregnancy: Management of diabetes and its complications from pre-conception to the postnatal period Clinical Guideline CG63 (26th March 2008)
This guidance covers the care and treatment of pregnant women with diabetes in the NHS in England and Wales. It also covers the care of their newborn babies. It is written for women who have diabetes or develop it in pregnancy, but it may also be useful for their families or for anyone with an interest in the condition.
Click here for the NICE Guidance
Click here for the Full Guidance
Click here for the Quick Reference Guide
Click here for the Search Strategies
Click here for the Evidence Tables
Click here for the Understanding NICE Guidance
Click here for the Costing Template
Click here for the Costing Report
Intraoperative nerve monitoring during thyroid surgery Interventional Procedure Guidance IPG255 (26th March 2008)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on intraoperative nerve monitoring during thyroid surgery. The thyroid gland lies close to the vocal cords and the nerves that control movement of the vocal cords (recurrent laryngeal nerves). When surgery is performed on the thyroid gland, a nerve monitor is sometimes used during the operation with the aim of helping to prevent potential damage to the nerves.
Click here for the Guidance
Click here for the Understanding NICE Guidance
Click here for the Consultation comments
Maternal and Child Nutrition Public Health Programme Guidance PH011 (26th March 2008)
This guidance aims to address disparities in the nutrition of low-income and other disadvantaged groups compared with the general population. It is relevant for all women who are pregnant (or planning to become pregnant), mothers of children aged under 5 and others who care for children aged under 5. The guidance complements and supports, but does not replace, NICE clinical guidelines on: antenatal care, diabetes in pregnancy, intrapartum and postnatal care.
Click here for the Guidance
Click here for the Quick Reference Guide (Professionals)
Click here for the Quick Reference Guide (Public)
Click here for the Costing Statement
Mental Wellbeing of Children in Primary Education Public Health Intervention Guidance PH12 (26th March 2008)
This guidance is for teachers, school governors and professionals with public health as part of their remit working in education, local authorities, the NHS and the wider public, independent, voluntary and community sectors. Children's social and emotional wellbeing is important in its own right but also because it affects their physical health (both as a child and as an adult) and can determine how well they do at school. Good social, emotional and psychological health helps protect children against emotional and behavioural problems, violence and crime, teenage pregnancy and the misuse of drugs and alcohol. The guidance complements and supports, but does not replace, NICE guidance on depression in children and young people and parent training and education in the management of children with conduct disorders.
Click here for the Guidance
Click here for the Quick Reference Guide
Click here for the Costing statement
Prophylaxis against infective endocarditis Clinical Guideline CG64 (26th March 2008)
The advice in this NICE guideline covers: Patients who are at risk of infective endocarditis, specifically: adults and children with certain problems affecting the structure of the heart (such as a replacement heart valve or hypertrophic cardiomyopathy); adults and children who have previously had infective endocarditis (whether or not they have an underlying cardiac problem); people having any of these procedures: any dental procedure; any obstetric or gynaecological procedure, or childbirth; any procedure on the bladder or urine system; any procedure on the gullet, stomach or intestines; any procedure on the airways, including ear, nose and throat procedures and bronchoscopy (a test used to diagnose some lung problems). It does not specifically look at: people at risk of infective endocarditis who do not have heart problems (such as intravenous drug users); and people having procedures that aren't in the list above.
Click here for the NICE Guidance
Click here for the Appendices
Click here for the Quick Reference Guide
Click here for the Understanding NICE Guidance
Click here for the Cost Template
Click here for the Costing Report
Sleep Apnoea – continuous positive airways pressure (CPAP) Technology Appraisal TA139 (26th March 2008)
CPAP is recommended as a possible treatment for adults with moderate or severe sleep apnoea. CPAP may also be a possible treatment for people with mild sleep apnoea, but only if: their symptoms affect their quality of life and ability to go about their daily activities, and lifestyle advice (for example about losing weight, stopping smoking and cutting down on alcohol; and all other possible treatments have not worked or are not appropriate for that person. A person with sleep apnoea should be assessed and treated by a specialist in sleep disorders.
Click here for the Guidance
Click here for the Quick Reference Guide
Click here for the Understanding NICE Guidance
Click here for the Audit Support
Click here for the Cost Template
Suburethral synthetic sling insertion for stress urinary incontinence in men Interventional Procedure Guidance (IPG256)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on suburethral synthetic sling insertion for stress urinary incontinence in men. Following surgery to remove the prostate, many men develop leakage of urine during movements such as coughing, sneezing or laughing, which is known as stress incontinence. A sling can be inserted in the pelvic region to support or compress the urethra (the tube that carries urine from the bladder and through the penis) to prevent urine leakage.
Click here for the Guidance
Click here for the Understanding NICE Guidance
Click here for the Consultation Comments
Preventing the uptake of smoking by children: consultation on the draft guidance (19th March 2008)
Consultation on the draft guidance relating to “Mass-media and point-of-sales measures to prevent the uptake of smoking by children and young people”. Registered stakeholders are invited to comment on the draft guidance document which entails the draft recommendations. This consultation will take place between Wednesday 19 March and Friday 18 April 2008.
Click here for the Draft Guidance
Click here for the Comments Form
Rimonabant for the treatment of overweight and obese patients: Final appraisal determination (26th March 2008)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on rimonabant for the treatment of overweight and obese patients and submitted it to the Institute. The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Please note that the appeal period for this appraisal will close at 5pm on 9 April 2008.
Click here for the Final Appraisal Determination
Click here for the Consultee and commentator comments on the ACD
Click here for the Response to consultee, commentator and public comments
Click here for the ERG Appraisal of additional information
Click here for the Submission from the National Obesity Forum
Macular degeneration (age-related) – pegaptanib and ranibizumab: Final Appraisal Determination (1st April 2008)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on pegaptanib and ranibizumab for the treatment of age-related macular degeneration and submitted it to the Institute. The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Please note that the appeal period for this appraisal will close at 5pm on 16 April 2008.
Click here for the Final Appraisal Determination
Click here for the Response to consultee, commentator and public comments
Click here for the Consultee and commentator comments on the ACD
Click here for the Expert Comments on the ACD
Click here for the Report on public comments received on the ACD
Click here for the Additional scenario analysis undertaken by the Assessment Group
Click here for the Additional scenario analysis undertaken by the Decision Support Unit
NICE has carried out a review of ‘The guidelines manual’. This document describes the detailed process and methodology used to produce NICE clinical guidelines. It applies to both the NICE’s standard clinical guidelines and short clinical guidelines programmes. The draft update of ‘The guidelines manual’ is now open for consultation. Closing date for comments is 1st July 2008.
Click here for the Chapters
Click here for the Appendices
Click here for the Comments Proforma
Antenatal care: routine care for the healthy pregnant women Clinical Guideline CG62 (26th March 2008)
The advice in the NICE guideline covers: the routine care that all healthy women can expect to receive during their pregnancy. It does not specifically look at: women who are pregnant with more than one baby, women with certain medical conditions or women who develop a health problem during their pregnancy. This is an update of advice on 'Antenatal care: routine care for the healthy pregnant woman' that NICE produced in 2003.
Click here for the NICE Guideline
Click here for the Quick Reference Guide
Click here for the Full Guideline
Click here for the Search Strategies
Click here for the Evidence Tables
Click here for the Excluded Studies
Click here for Understanding NICE Guidance
Click here for the Costing Report
Click here for the Costing Template
Asthma (in adults) – corticosteroids Technology Appraisal TA138 (26th March 2008)
This guidance covers the use of inhaled corticosteroids to treat adults and children aged 12 years and over with chronic asthma in the NHS in England and Wales. It is written for people with chronic asthma but it may also be useful for their families or carers or anyone with an interest in the condition.
Click here for the Guidance
Click here for the Quick Reference Guide
Click here for the Understanding NICE Guidance
Click here for the Costing Statement
Click here for the Audit Support
Diabetes in Pregnancy: Management of diabetes and its complications from pre-conception to the postnatal period Clinical Guideline CG63 (26th March 2008)
This guidance covers the care and treatment of pregnant women with diabetes in the NHS in England and Wales. It also covers the care of their newborn babies. It is written for women who have diabetes or develop it in pregnancy, but it may also be useful for their families or for anyone with an interest in the condition.
Click here for the NICE Guidance
Click here for the Full Guidance
Click here for the Quick Reference Guide
Click here for the Search Strategies
Click here for the Evidence Tables
Click here for the Understanding NICE Guidance
Click here for the Costing Template
Click here for the Costing Report
Intraoperative nerve monitoring during thyroid surgery Interventional Procedure Guidance IPG255 (26th March 2008)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on intraoperative nerve monitoring during thyroid surgery. The thyroid gland lies close to the vocal cords and the nerves that control movement of the vocal cords (recurrent laryngeal nerves). When surgery is performed on the thyroid gland, a nerve monitor is sometimes used during the operation with the aim of helping to prevent potential damage to the nerves.
Click here for the Guidance
Click here for the Understanding NICE Guidance
Click here for the Consultation comments
Maternal and Child Nutrition Public Health Programme Guidance PH011 (26th March 2008)
This guidance aims to address disparities in the nutrition of low-income and other disadvantaged groups compared with the general population. It is relevant for all women who are pregnant (or planning to become pregnant), mothers of children aged under 5 and others who care for children aged under 5. The guidance complements and supports, but does not replace, NICE clinical guidelines on: antenatal care, diabetes in pregnancy, intrapartum and postnatal care.
Click here for the Guidance
Click here for the Quick Reference Guide (Professionals)
Click here for the Quick Reference Guide (Public)
Click here for the Costing Statement
Mental Wellbeing of Children in Primary Education Public Health Intervention Guidance PH12 (26th March 2008)
This guidance is for teachers, school governors and professionals with public health as part of their remit working in education, local authorities, the NHS and the wider public, independent, voluntary and community sectors. Children's social and emotional wellbeing is important in its own right but also because it affects their physical health (both as a child and as an adult) and can determine how well they do at school. Good social, emotional and psychological health helps protect children against emotional and behavioural problems, violence and crime, teenage pregnancy and the misuse of drugs and alcohol. The guidance complements and supports, but does not replace, NICE guidance on depression in children and young people and parent training and education in the management of children with conduct disorders.
Click here for the Guidance
Click here for the Quick Reference Guide
Click here for the Costing statement
Prophylaxis against infective endocarditis Clinical Guideline CG64 (26th March 2008)
The advice in this NICE guideline covers: Patients who are at risk of infective endocarditis, specifically: adults and children with certain problems affecting the structure of the heart (such as a replacement heart valve or hypertrophic cardiomyopathy); adults and children who have previously had infective endocarditis (whether or not they have an underlying cardiac problem); people having any of these procedures: any dental procedure; any obstetric or gynaecological procedure, or childbirth; any procedure on the bladder or urine system; any procedure on the gullet, stomach or intestines; any procedure on the airways, including ear, nose and throat procedures and bronchoscopy (a test used to diagnose some lung problems). It does not specifically look at: people at risk of infective endocarditis who do not have heart problems (such as intravenous drug users); and people having procedures that aren't in the list above.
Click here for the NICE Guidance
Click here for the Appendices
Click here for the Quick Reference Guide
Click here for the Understanding NICE Guidance
Click here for the Cost Template
Click here for the Costing Report
Sleep Apnoea – continuous positive airways pressure (CPAP) Technology Appraisal TA139 (26th March 2008)
CPAP is recommended as a possible treatment for adults with moderate or severe sleep apnoea. CPAP may also be a possible treatment for people with mild sleep apnoea, but only if: their symptoms affect their quality of life and ability to go about their daily activities, and lifestyle advice (for example about losing weight, stopping smoking and cutting down on alcohol; and all other possible treatments have not worked or are not appropriate for that person. A person with sleep apnoea should be assessed and treated by a specialist in sleep disorders.
Click here for the Guidance
Click here for the Quick Reference Guide
Click here for the Understanding NICE Guidance
Click here for the Audit Support
Click here for the Cost Template
Suburethral synthetic sling insertion for stress urinary incontinence in men Interventional Procedure Guidance (IPG256)
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on suburethral synthetic sling insertion for stress urinary incontinence in men. Following surgery to remove the prostate, many men develop leakage of urine during movements such as coughing, sneezing or laughing, which is known as stress incontinence. A sling can be inserted in the pelvic region to support or compress the urethra (the tube that carries urine from the bladder and through the penis) to prevent urine leakage.
Click here for the Guidance
Click here for the Understanding NICE Guidance
Click here for the Consultation Comments
Preventing the uptake of smoking by children: consultation on the draft guidance (19th March 2008)
Consultation on the draft guidance relating to “Mass-media and point-of-sales measures to prevent the uptake of smoking by children and young people”. Registered stakeholders are invited to comment on the draft guidance document which entails the draft recommendations. This consultation will take place between Wednesday 19 March and Friday 18 April 2008.
Click here for the Draft Guidance
Click here for the Comments Form
Rimonabant for the treatment of overweight and obese patients: Final appraisal determination (26th March 2008)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on rimonabant for the treatment of overweight and obese patients and submitted it to the Institute. The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Please note that the appeal period for this appraisal will close at 5pm on 9 April 2008.
Click here for the Final Appraisal Determination
Click here for the Consultee and commentator comments on the ACD
Click here for the Response to consultee, commentator and public comments
Click here for the ERG Appraisal of additional information
Click here for the Submission from the National Obesity Forum
Macular degeneration (age-related) – pegaptanib and ranibizumab: Final Appraisal Determination (1st April 2008)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on pegaptanib and ranibizumab for the treatment of age-related macular degeneration and submitted it to the Institute. The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Please note that the appeal period for this appraisal will close at 5pm on 16 April 2008.
Click here for the Final Appraisal Determination
Click here for the Response to consultee, commentator and public comments
Click here for the Consultee and commentator comments on the ACD
Click here for the Expert Comments on the ACD
Click here for the Report on public comments received on the ACD
Click here for the Additional scenario analysis undertaken by the Assessment Group
Click here for the Additional scenario analysis undertaken by the Decision Support Unit
No comments:
Post a Comment